NO20063144L - Anti-aldringspreparater - Google Patents

Anti-aldringspreparater

Info

Publication number
NO20063144L
NO20063144L NO20063144A NO20063144A NO20063144L NO 20063144 L NO20063144 L NO 20063144L NO 20063144 A NO20063144 A NO 20063144A NO 20063144 A NO20063144 A NO 20063144A NO 20063144 L NO20063144 L NO 20063144L
Authority
NO
Norway
Prior art keywords
aging
long period
composition
reduced coenzyme
time
Prior art date
Application number
NO20063144A
Other languages
English (en)
Norwegian (no)
Inventor
Kenji Fujii
Taizo Kawabe
Hiroshi Kubo
Keiichi Higuchi
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of NO20063144L publication Critical patent/NO20063144L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20063144A 2004-01-08 2006-07-06 Anti-aldringspreparater NO20063144L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004002863 2004-01-08
PCT/JP2005/000430 WO2005065672A1 (fr) 2004-01-08 2005-01-07 Composition antivieillissement

Publications (1)

Publication Number Publication Date
NO20063144L true NO20063144L (no) 2006-10-09

Family

ID=34747062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063144A NO20063144L (no) 2004-01-08 2006-07-06 Anti-aldringspreparater

Country Status (10)

Country Link
EP (1) EP1701716A1 (fr)
JP (1) JP2007517761A (fr)
KR (1) KR20060134057A (fr)
CN (1) CN1909895A (fr)
AU (1) AU2005204044B2 (fr)
CA (1) CA2550186A1 (fr)
NO (1) NO20063144L (fr)
RU (1) RU2006128735A (fr)
TW (1) TW200526193A (fr)
WO (1) WO2005065672A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007028997A (ja) * 2005-07-27 2007-02-08 Kanebo Seiyaku Kk 生薬エキス配合流動食及びその使用
EP1927349A4 (fr) 2005-09-22 2010-05-05 Kaneka Corp Composition destinée à prolonger la vie et procédé destiné à prolonger la vie
WO2011040071A1 (fr) 2009-09-29 2011-04-07 株式会社資生堂 Composition antioxydante
US20130195925A1 (en) * 2011-11-03 2013-08-01 Vaskin, Llc Anti aging application and method for treating aging
JP6457497B2 (ja) * 2014-04-25 2019-01-23 ヤクルトヘルスフーズ株式会社 老化に伴う身体的症状の発現遅延剤
CN104474527B (zh) * 2014-11-24 2015-10-07 南京泛成生物化工有限公司 一种含富硒酵母的组合物及其应用
CN111603552A (zh) * 2020-07-02 2020-09-01 中健智诊(重庆)生物研究院 一种抗衰老组合物及其应用
CN111973477A (zh) * 2020-09-04 2020-11-24 湖南御家化妆品制造有限公司 一种艾地苯醌、微晶纤维素复合载体的制备方法及化妆品

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2751454A1 (de) * 1976-11-19 1978-06-15 New England Inst Inc Steuerung und umkehr der immunologischen alterung
ATE240661T1 (de) * 1997-03-27 2003-06-15 Michael J Sole Ernährungszusammensetzung zur verbesserung der zellenenergie
IT1304406B1 (it) * 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6403116B1 (en) * 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US6506915B1 (en) * 2001-06-14 2003-01-14 Daniel David West Synthesis of coenzyme Q10 ubiquinone
TWI329513B (en) * 2001-10-12 2010-09-01 Kaneka Corp Use of reduced coenzyme q for lessening oxidative stress
JP2003135022A (ja) * 2001-10-31 2003-05-13 Crescendo Corporation コエンザイムｑ１０
TWI322008B (en) * 2003-01-31 2010-03-21 Kaneka Corp Fatigue improving agent including reduced coenzyme q10
US7438903B2 (en) * 2003-06-06 2008-10-21 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10

Also Published As

Publication number Publication date
WO2005065672A1 (fr) 2005-07-21
AU2005204044A1 (en) 2005-07-21
RU2006128735A (ru) 2008-02-20
JP2007517761A (ja) 2007-07-05
KR20060134057A (ko) 2006-12-27
CA2550186A1 (fr) 2005-07-21
EP1701716A1 (fr) 2006-09-20
AU2005204044B2 (en) 2010-07-22
TW200526193A (en) 2005-08-16
CN1909895A (zh) 2007-02-07

Similar Documents

Publication Publication Date Title
NO20063144L (no) Anti-aldringspreparater
US20200147033A1 (en) Nutraceutical composition for pde4 inhibition, enhanced dopamine metabolism and long term potentiation
NZ700984A (en) N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
NO20062512L (no) Sammensetninger og doseringsformer for forbedret absorpsjon av gabapentin og pregabalin
UA98813C2 (ru) Производные спирогетероциклического пирролидиндиона, способ их получения, пестицидная композиция и способ борьбы с вредителями
MX2008001402A (es) Inhibidores macrociclicos del virus de la hepatitis c.
UA91406C2 (ru) Производные бициклического бисамида, пестицидная композиция и способ борьбы с вредителями
ECSP088367A (es) Derivados de bifenilo y su uso en el tratamiento de la hepatitis c
NO20081478L (no) Et synergetisk biosid og fremgangsmate for a kontrollere veksten av mikroorganismer
NO20050840L (no) Farmasoytiske preparater og fremgangsmater for modifisert frigjoring av statin-legemidler
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
NO20062082L (no) Pellets inneholdende venlafaksinhydroklorid
SG170751A1 (en) Extractions and methods comprising elder species
WO2006053564A3 (fr) Stabilisation de granules comprenant des composes actifs
Tian et al. Nicotine enhances contextual fear memory reconsolidation in rats
WO2006069048A3 (fr) Réduction de la croissance des poils
BR112013003323A2 (pt) método de melhorar crescimento vegetal pela redução de infecções fúngicas
SA112330457B1 (ar) مشتقات فينيل- ايزواوكسازول وعملية تحضيرها
WO2008057464A3 (fr) Compositions et procédés servant à améliorer la biodisponibilité de la liothyronine
CN103766380A (zh) 一种含有呋虫胺和噻呋酰胺的农药组合物
TW200715997A (en) Method for prevention of formation of abnormal odor in beverage composition
NO20070212L (no) Vandige dispersjoner av aktive substanser som har lav vannloslighet eller er vannuloslige, og tort pulver fremstilt derav
NO20043265L (no) Anvendelse av polysakkaridderivater som anti-infeksiose stoffer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application